Comprehensive comparative and semiquantitative proteome of a very low number of native and matched Epstein-Barr-Virus-transformed B lymphocytes infiltrating human melanoma

Journal of Proteome Research

Volumn 13, Issue 6, 2014, Pages 2830-2845

  Maurer, Margarita ^a   Müller, André C ^b   Parapatics, Katja ^b   Pickl, Winfried F ^c   Wagner, Christine ^a   Rudashevskaya, Elena L ^b   Breitwieser, Florian P ^b   Colinge, Jacques ^b   Garg, Kanika ^a   Griss, Johannes ^a   Bennett, Keiryn L ^b   Wagner, Stephan N ^a  

^a Universitatsklinik fur Dermatologie   (Austria)

^b ERICH SCHMID INSTITUTE OF MATERIALS SCIENCE   (Austria)

^c MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

EBV transformed B cells; FASP; iTRAQ; melanoma; Orbitrap; TIBC; tumor infiltrating B cells; ultrasensitive proteomics

Indexed keywords

CPG OLIGODEOXYNUCLEOTIDE; PROTEOME; MESSENGER RNA;

APOPTOSIS; ARTICLE; B LYMPHOCYTE; B LYMPHOCYTE ACTIVATION; CASE REPORT; CELL CYCLE; CELL ISOLATION; CELL PROLIFERATION; CELL TRANSFORMATION; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOKINE RESPONSE; EPSTEIN BARR VIRUS; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; LYMPHOCYTIC INFILTRATION; METASTATIC MELANOMA; PRIORITY JOURNAL; PROTEOMICS; TUMOR ASSOCIATED LEUKOCYTE; CELL SEPARATION; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE ONTOLOGY; GENETICS; IMMUNOLOGY; MELANOMA; METABOLISM; MOLECULAR GENETICS; PATHOLOGY; PHYSIOLOGY; SECONDARY; TUMOR CELL CULTURE; VIROLOGY;

B-LYMPHOCYTES; CELL PROLIFERATION; CELL SEPARATION; GENE EXPRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE ONTOLOGY; HERPESVIRUS 4, HUMAN; HUMANS; MELANOMA; MOLECULAR SEQUENCE ANNOTATION; PROTEOME; RNA, MESSENGER; TUMOR CELLS, CULTURED;

EID: 84902094502     PISSN: 15353893     EISSN: 15353907     Source Type: Journal    
DOI: 10.1021/pr401270y     Document Type: Article

References (92)

1. Erdag, G.; Schaefer, J. T.; Smolkin, M. E.; Deacon, D. H.; Shea, S. M.; Dengel, L. T.; Patterson, J. W.; Slingluff, C. L., Jr. Immunotype and immunohistologic characteristics of tumor-infiltrating immune cells are associated with clinical outcome in metastatic melanoma Cancer Res. 2012, 72, 1070-1080
2. Man, Y. G.; Stojadinovic, A.; Mason, J.; Avital, I.; Bilchik, A.; Bruecher, B.; Protic, M.; Nissan, A.; Izadjoo, M.; Zhang, X.; Jewett, A. Tumor-infiltrating immune cells promoting tumor invasion and metastasis: existing theories J. Cancer 2013, 4, 84-95
3. Linnebacher, M.; Maletzki, C. Tumor-infiltrating B cells: The ignored players in tumor immunology Oncoimmunology 2012, 1, 1186-1188
4. Maletzki, C.; Jahnke, A.; Ostwald, C.; Klar, E.; Prall, F.; Linnebacher, M. Ex-vivo clonally expanded B lymphocytes infiltrating colorectal carcinoma are of mature immunophenotype and produce functional IgG PloS One 2012, 7, e32639
5. DiLillo, D. J.; Yanaba, K.; Tedder, T. F. B cells are required for optimal CD4+ and CD8+ T cell tumor immunity: therapeutic B cell depletion enhances B16 melanoma growth in mice J. Immunol. 2010, 184, 4006-4016
6. Nelson, B. H. CD20+ B cells: the other tumor-infiltrating lymphocytes J. Immunol. 2010, 185, 4977-4982
7. Coronella-Wood, J. A.; Hersh, E. M. Naturally occurring B-cell responses to breast cancer Cancer Immunol. Immunother. 2003, 52, 715-738
8. Mahmoud, S. M.; Lee, A. H.; Paish, E. C.; Macmillan, R. D.; Ellis, I. O.; Green, A. R. The prognostic significance of B lymphocytes in invasive carcinoma of the breast Breast Cancer Res. Treat. 2012, 132, 545-553
9. Milne, K.; Kobel, M.; Kalloger, S. E.; Barnes, R. O.; Gao, D.; Gilks, C. B.; Watson, P. H.; Nelson, B. H. Systematic analysis of immune infiltrates in high-grade serous ovarian cancer reveals CD20, FoxP3 and TIA-1 as positive prognostic factors PloS One 2009, 4, e6412
10. Coronella, J. A.; Telleman, P.; Kingsbury, G. A.; Truong, T. D.; Hays, S.; Junghans, R. P. Evidence for an antigen-driven humoral immune response in medullary ductal breast cancer Cancer Res. 2001, 61, 7889-7899
11. Nielsen, J. S.; Sahota, R. A.; Milne, K.; Kost, S. E.; Nesslinger, N. J.; Watson, P. H.; Nelson, B. H. CD20+ tumor-infiltrating lymphocytes have an atypical CD27- memory phenotype and together with CD8+ T cells promote favorable prognosis in ovarian cancer Clin. Cancer Res. 2012, 18, 3281-3292
12. Pretscher, D.; Distel, L. V.; Grabenbauer, G. G.; Wittlinger, M.; Buettner, M.; Niedobitek, G. Distribution of immune cells in head and neck cancer: CD8+ T-cells and CD20+ B-cells in metastatic lymph nodes are associated with favourable outcome in patients with oro- and hypopharyngeal carcinoma BMC Cancer 2009, 9, 292
13. Ladanyi, A.; Kiss, J.; Mohos, A.; Somlai, B.; Liszkay, G.; Gilde, K.; Fejos, Z.; Gaudi, I.; Dobos, J.; Timar, J. Prognostic impact of B-cell density in cutaneous melanoma Cancer Immunol. Immunother. 2011, 60, 1729-1738
14. Yanaba, K.; Bouaziz, J. D.; Matsushita, T.; Magro, C. M.; St Clair, E. W.; Tedder, T. F. B-lymphocyte contributions to human autoimmune disease Immunol. Rev. 2008, 223, 284-299
15. Ammirante, M.; Luo, J. L.; Grivennikov, S.; Nedospasov, S.; Karin, M. B-cell-derived lymphotoxin promotes castration-resistant prostate cancer Nature 2010, 464, 302-305
16. Olkhanud, P. B.; Damdinsuren, B.; Bodogai, M.; Gress, R. E.; Sen, R.; Wejksza, K.; Malchinkhuu, E.; Wersto, R. P.; Biragyn, A. Tumor-evoked regulatory B cells promote breast cancer metastasis by converting resting CD4(+) T cells to T-regulatory cells Cancer Res. 2011, 71, 3505-3515
17. Staquicini, F. I.; Tandle, A.; Libutti, S. K.; Sun, J.; Zigler, M.; Bar-Eli, M.; Aliperti, F.; Perez, E. C.; Gershenwald, J. E.; Mariano, M.; Pasqualini, R.; Arap, W.; Lopes, J. D. A subset of host B lymphocytes controls melanoma metastasis through a melanoma cell adhesion molecule/MUC18-dependent interaction: evidence from mice and humans Cancer Res. 2008, 68, 8419-8428
18. Lindner, S.; Dahlke, K.; Sontheimer, K.; Hagn, M.; Kaltenmeier, C.; Barth, T. F.; Beyer, T.; Reister, F.; Fabricius, D.; Lotfi, R.; Lunov, O.; Nienhaus, G. U.; Simmet, T.; Kreienberg, R.; M?ller, P.; Schrezenmeier, H.; Jahrsdorfer, B. Interleukin 21-induced granzyme B-expressing B cells infiltrate tumors and regulate T cells Cancer Res. 2013, 73, 2468-2479
19. Meyer, S.; Fuchs, T. J.; Bosserhoff, A. K.; Hofstadter, F.; Pauer, A.; Roth, V.; Buhmann, J. M.; Moll, I.; Anagnostou, N.; Brandner, J. M.; Ikenberg, K.; Moch, H.; Landthaler, M.; Vogt, T.; Wild, P. J. A seven-marker signature and clinical outcome in malignant melanoma: a large-scale tissue-microarray study with two independent patient cohorts PloS One 2012, 7, e38222
20. Pinc, A.; Somasundaram, R.; Wagner, C.; Hormann, M.; Karanikas, G.; Jalili, A.; Bauer, W.; Brunner, P.; Grabmeier-Pfistershammer, K.; Gschaider, M.; Lai, C. Y.; Hsu, M. Y.; Herlyn, M.; Stingl, G.; Wagner, S. N. Targeting CD20 in melanoma patients at high risk of disease recurrence Mol. Ther. 2012, 20, 1056-1062
21. Abes, R.; Gelize, E.; Fridman, W. H.; Teillaud, J. L. Long-lasting antitumor protection by anti-CD20 antibody through cellular immune response Blood 2010, 116, 926-934
22. Maurer, M.; Somasundaram, R.; Herlyn, M.; Wagner, S. N. Immunotargeting of tumor subpopulations in melanoma patients A paradigm shift in therapy approaches Oncoimmunology 2012, 1, 1454-1456
23. DiLillo, D. J.; Yanaba, K.; Tedder, T. F. B Cells Are Required for Optimal CD4(+) and CD8(+) T Cell Tumor Immunity: Therapeutic B Cell Depletion Enhances B16 Melanoma Growth in Mice J. Immunol. 2010, 184, 4006-4016
24. Thompson, M. P.; Kurzrock, R. Epstein-Barr virus and cancer Clin. Cancer Res. 2004, 10, 803-821
25. Murray, P. G.; Young, L. S. The Role of the Epstein-Barr virus in human disease Front. Biosci. 2002, 7, d519-540
26. Young, L. S.; Rickinson, A. B. Epstein-Barr virus: 40 years on Nat. Rev. Cancer 2004, 4, 757-768
27. Pattengale, P. K.; Smith, R. W.; Gerber, P. Selective transformation of B lymphocytes by E.B. virus Lancet 1973, 2, 93-94
28. Neitzel, H. A routine method for the establishment of permanent growing lymphoblastoid cell lines Hum. Genet. 1986, 73, 320-326
29. Henderson, E.; Miller, G.; Robinson, J.; Heston, L. Efficiency of transformation of lymphocytes by Epstein-Barr virus Virology 1977, 76, 152-163
30. Hui-Yuen, J.; McAllister, S.; Koganti, S.; Hill, E.; Bhaduri-McIntosh, S. Establishment of Epstein-Barr virus growth-transformed lymphoblastoid cell lines J. Visualized Exp. 2011, 57) e3321
31. Pelloquin, F.; Lamelin, J. P.; Lenoir, G. M. Human B lymphocytes immortalization by Epstein-Barr virus in the presence of cyclosporin A In Vitro Cell. Dev. Biol. 1986, 22, 689-694
32. Pressman, S.; Rotter, J. I. Epstein-Barr virus transformation of cryopreserved lymphocytes: prolonged experience with technique Am. J. Hum. Genet. 1991, 49, 467
33. Amoli, M. M.; Carthy, D.; Platt, H.; Ollier, W. E. EBV Immortalization of human B lymphocytes separated from small volumes of cryo-preserved whole blood Int. J. Mol. Epidemiol. Genet. 2008, 37 (Suppl 1) i41-45
34. Fraussen, J.; Vrolix, K.; Martinez-Martinez, P.; Losen, M.; Meulemans, E.; De Baets, M. H.; Stinissen, P.; Somers, V. A novel method for making human monoclonal antibodies J. Autoimmun. 2010, 35, 130-134
35. Thorley-Lawson, D. A.; Gross, A. Persistence of the Epstein-Barr virus and the origins of associated lymphomas N. Engl. J. Med. 2004, 350, 1328-1337
36. Kennedy, D. O.; Agrawal, M.; Shen, J.; Terry, M. B.; Zhang, F. F.; Senie, R. T.; Motykiewicz, G.; Santella, R. M. DNA repair capacity of lymphoblastoid cell lines from sisters discordant for breast cancer J. Natl. Cancer Inst. 2005, 97, 127-132
37. Thierfelder, N.; Demuth, I.; Burghardt, N.; Schmelz, K.; Sperling, K.; Chrzanowska, K. H.; Seemanova, E.; Digweed, M. Extreme variation in apoptosis capacity amongst lymphoid cells of Nijmegen breakage syndrome patients Eur. J. Cell Biol. 2008, 87, 111-121
38. Toda, T.; Sugimoto, M. Proteome analysis of Epstein-Barr virus-transformed B-lymphoblasts and the proteome database J. Chromatogr, B 2003, 787, 197-206
39. Caron, M.; Imam-Sghiouar, N.; Poirier, F.; Le Caer, J. P.; Labas, V.; Joubert-Caron, R. Proteomic map and database of lymphoblastoid proteins J. Chromatogr B 2002, 771, 197-209
40. Dirksen, E. H. C.; Cloos, J.; Braakhuis, B. J. M.; Brakenhoff, R. H.; Heck, A. J. R.; Slijper, M. Human lymphoblastoid proteome analysis reveals a role for the inhibitor of acetyltransferases complex in DNA double-strand break response Cancer Res. 2006, 66, 1473-1480
41. Gkiafi, Z.; Panayotou, G. Comparative Proteomic Analysis Implicates COMMD Proteins as Epstein-Barr Virus Targets in the BL41 Burkitt's Lymphoma Cell Line J. Proteome Res. 2011, 10, 2959-2968
42. Toda, T.; Sugimoto, M.; Omori, A.; Matsuzaki, T.; Furuichi, Y.; Kimura, N. Proteomic analysis of Epstein-Barr virus-transformed human B-lymphoblastiod cell lines before and after immortalization Electrophoresis 2000, 21, 1814-1822
43. Watson, D. B.; Burns, G. F.; Mackay, I. R. In vitro growth of B lymphocytes infiltrating human melanoma tissue by transformation with EBV: evidence for secretion of anti-melanoma antibodies by some transformed cells J. Immunol. 1983, 130, 2442-2447
44. Zijno, A.; Porcedda, P.; Saini, F.; Allione, A.; Garofalo, B.; Marcon, F.; Guarrera, S.; Turinetto, V.; Minieri, V.; Funaro, A.; Crebelli, R.; Giachino, C.; Matullo, G. Unsuitability of lymphoblastoid cell lines as surrogate of cryopreserved isolated lymphocytes for the analysis of DNA double-strand break repair activity Mutation Res. 2010, 684, 98-105
45. Trenz, K.; Schutz, P.; Speit, G. Radiosensitivity of lymphoblastoid cell lines with a heterozygous BRCA1 mutation is not detected by the comet assay and pulsed field gel electrophoresis Mutagenesis 2005, 20, 131-137
46. Mazzei, F.; Guarrera, S.; Allione, A.; Simonelli, V.; Narciso, L.; Barone, F.; Minoprio, A.; Ricceri, F.; Funaro, A.; D'Errico, M.; Vogel, U.; Matullo, G.; Dogliotti, E. 8-Oxoguanine DNA-glycosylase repair activity and expression: a comparison between cryopreserved isolated lymphocytes and EBV-derived lymphoblastoid cell lines Mutation Res. 2011, 718, 62-67
47. Maurer, M.; Muller, A. C.; Wagner, C.; Huber, M. L.; Rudashevskaya, E. L.; Wagner, S. N.; Bennett, K. L. Combining filter-aided sample preparation and pseudoshotgun technology to profile the proteome of a low number of early passage human melanoma cells J. Proteome Res. 2013, 12, 1040-1048
48. Wisniewski, J. R.; Zougman, A.; Nagaraj, N.; Mann, M. Universal sample preparation method for proteome analysis Nat. Methods 2009, 6, 359-362
49. Jalili, A.; Wagner, C.; Pashenkov, M.; Pathria, G.; Mertz, K. D.; Widlund, H. R.; Lupien, M.; Brunet, J. P.; Golub, T. R.; Stingl, G.; Fisher, D. E.; Ramaswamy, S.; Wagner, S. N. Dual suppression of the cyclin-dependent kinase inhibitors CDKN2C and CDKN1A in human melanoma J. Natl. Cancer Inst. 2012, 104, 1673-1679
50. Bennett, K. L.; Funk, M.; Tschernutter, M.; Breitwieser, F. P.; Planyavsky, M.; Ubaida Mohien, C.; Muller, A.; Trajanoski, Z.; Colinge, J.; Superti-Furga, G.; Schmidt-Erfurth, U. Proteomic analysis of human cataract aqueous humour: Comparison of one-dimensional gel LCMS with two-dimensional LCMS of unlabelled and iTRAQ(R)-labelled specimens J. Proteomics 2011, 74, 151-166
51. Olsen, J. V.; de Godoy, L. M.; Li, G.; Macek, B.; Mortensen, P.; Pesch, R.; Makarov, A.; Lange, O.; Horning, S.; Mann, M. Parts per million mass accuracy on an Orbitrap mass spectrometer via lock mass injection into a C-trap Mol. Cell. Proteomics 2005, 4, 2010-2021
52. Colinge, J.; Masselot, A.; Giron, M.; Dessingy, T.; Magnin, J. OLAV: towards high-throughput tandem mass spectrometry data identification Proteomics 2003, 3, 1454-1463
53. Breitwieser, F. P.; Muller, A.; Dayon, L.; Kocher, T.; Hainard, A.; Pichler, P.; Schmidt-Erfurth, U.; Superti-Furga, G.; Sanchez, J. C.; Mechtler, K.; Bennett, K. L.; Colinge, J. General statistical modeling of data from protein relative expression isobaric tags J. Proteome Res. 2011, 10, 2758-2766
54. Ashburner, M.; Ball, C. A.; Blake, J. A.; Botstein, D.; Butler, H.; Cherry, J. M.; Davis, A. P.; Dolinski, K.; Dwight, S. S.; Eppig, J. T.; Harris, M. A.; Hill, D. P.; Issel-Tarver, L.; Kasarskis, A.; Lewis, S.; Matese, J. C.; Richardson, J. E.; Ringwald, M.; Rubin, G. M.; Sherlock, G. Gene ontology: tool for the unification of biology. The Gene Ontology Consortium Nat. Genetics 2000, 25, 25-29
55. Altelaar, A. F.; Heck, A. J. Trends in ultrasensitive proteomics Curr. Opin. Chem. Biol. 2012, 16, 206-213
56. Wisniewski, J. R.; Zougman, A.; Nagaraj, N.; Mann, M. Universal sample preparation method for proteome analysis Nat. Methods 2009, 6, 359-362
57. Schlatzer, D. M.; Sugalski, J.; Dazard, J. E.; Chance, M. R.; Anthony, D. D. A quantitative proteomic approach for detecting protein profiles of activated human myeloid dendritic cells J. Immunol. Methods 2012, 375, 39-45
58. Wisniewski, J. R.; Ostasiewicz, P.; Mann, M. High recovery FASP applied to the proteomic analysis of microdissected formalin fixed paraffin embedded cancer tissues retrieves known colon cancer markers J. Proteome Res. 2011, 10, 3040-3049
59. Carter, K. L.; Cahir-McFarland, E.; Kieff, E. Epstein-barr virus-induced changes in B-lymphocyte gene expression J. Virol. 2002, 76, 10427-10436
60. Baran-Marszak, F.; Fagard, R.; Girard, B.; Camilleri-Broet, S.; Zeng, F.; Lenoir, G. M.; Raphael, M.; Feuillard, J. Gene array identification of Epstein Barr virus-regulated cellular genes in EBV-converted Burkitt lymphoma cell lines Lab. Invest. 2002, 82, 1463-1479
61. Caliskan, M.; Cusanovich, D. A.; Ober, C.; Gilad, Y. The effects of EBV transformation on gene expression levels and methylation profiles Hum. Mol. Genet. 2011, 20, 1643-1652
62. Abdallah, C.; Dumas-Gaudot, E.; Renaut, J.; Sergeant, K. Gel-based and gel-free quantitative proteomics approaches at a glance Int. J. Plant Genomics 2012, 2012, 494572
63. Darekar, S.; Georgiou, K.; Yurchenko, M.; Yenamandra, S. P.; Chachami, G.; Simos, G.; Klein, G.; Kashuba, E. Epstein-Barr virus immortalization of human B-cells leads to stabilization of hypoxia-induced factor 1 alpha, congruent with the Warburg effect PloS One 2012, 7, e42072
64. Clybouw, C.; McHichi, B.; Mouhamad, S.; Auffredou, M. T.; Bourgeade, M. F.; Sharma, S.; Leca, G.; Vazquez, A. EBV infection of human B lymphocytes leads to down-regulation of Bim expression: relationship to resistance to apoptosis J. Immunol. 2005, 175, 2968-2973
65. McClellan, M. J.; Khasnis, S.; Wood, C. D.; Palermo, R. D.; Schlick, S. N.; Kanhere, A. S.; Jenner, R. G.; West, M. J. Downregulation of integrin receptor-signaling genes by Epstein-Barr virus EBNA 3C via promoter-proximal and -distal binding elements J. Virol. 2012, 86, 5165-5178
66. Miyamoto, Y.; Koh, Y. H.; Park, Y. S.; Fujiwara, N.; Sakiyama, H.; Misonou, Y.; Ookawara, T.; Suzuki, K.; Honke, K.; Taniguchi, N. Oxidative stress caused by inactivation of glutathione peroxidase and adaptive responses Biol. Chem. 2003, 384, 567-574
67. Lassoued, S.; Ben Ameur, R.; Ayadi, W.; Gargouri, B.; Ben Mansour, R.; Attia, H. Epstein-Barr virus induces an oxidative stress during the early stages of infection in B lymphocytes, epithelial, and lymphoblastoid cell lines Mol. Cell. Biochem. 2008, 313, 179-186
68. Ranjan, D.; Siquijor, A.; Johnston, T. D.; Wu, G.; Nagabhuskahn, M. The effect of curcumin on human B-cell immortalization by Epstein-Barr virus Am. Surg. 1998, 64 (discussion 51-42) 47-51
69. Chen, C.; Jeon, H.; Johnston, T. D.; Gedaly, R.; McHugh, P. P.; Ranjan, D. Cyclosporin A-induced lipid and protein oxidation in human B-cells and in Epstein-Barr virus-infected B-cells is prevented by antioxidants J. Invest. Surg. 2008, 21, 201-208
70. Khatri, P.; Sirota, M.; Butte, A. J. Ten years of pathway analysis: current approaches and outstanding challenges PLoS Comput. Biol. 2012, 8, e1002375
71. Amundson, S. A.; Myers, T. G.; Fornace, A. J., Jr. Roles for p53 in growth arrest and apoptosis: putting on the brakes after genotoxic stress Oncogene 1998, 17, 3287-3299
72. Forte, E.; Luftig, M. A. MDM2-dependent inhibition of p53 is required for Epstein-Barr virus B-cell growth transformation and infected-cell survival J. Virol. 2009, 83, 2491-2499
73. Husaini, R.; Ahmad, M.; Soo-Beng Khoo, A. Epstein-Barr virus Latent Membrane Protein LMP1 reduces p53 protein levels independent of the PI3K-Akt pathway BMC Res. Notes 2011, 4, 551
74. Bernard, S.; Eilers, M. Control of cell proliferation and growth by Myc proteins Results Probl. Cell Differ. 2006, 42, 329-342
75. Faumont, N.; Durand-Panteix, S.; Schlee, M.; Gromminger, S.; Schuhmacher, M.; Holzel, M.; Laux, G.; Mailhammer, R.; Rosenwald, A.; Staudt, L. M.; Bornkamm, G. W.; Feuillard, J. c-Myc and Rel/NF-kappaB are the two master transcriptional systems activated in the latency III program of Epstein-Barr virus-immortalized B cells J. Virol. 2009, 83, 5014-5027
76. Kaiser, C.; Laux, G.; Eick, D.; Jochner, N.; Bornkamm, G. W.; Kempkes, B. The proto-oncogene c-myc is a direct target gene of Epstein-Barr virus nuclear antigen 2 J. Virol. 1999, 73, 4481-4484
77. Gomez-Curet, I.; Perkins, R. S.; Bennett, R.; Feidler, K. L.; Dunn, S. P.; Krueger, L. J. c-Myc inhibition negatively impacts lymphoma growth J. Pediatr. Surg. 2006, 41 (discussion 207-211) 207-211
78. Lee, J. E.; Nam, H. Y.; Shim, S. M.; Bae, G. R.; Han, B. G.; Jeon, J. P. Expression phenotype changes of EBV-transformed lymphoblastoid cell lines during long-term subculture and its clinical significance Cell Proliferation 2010, 43, 378-384
79. Bornkamm, G. W.; Hammerschmidt, W. Molecular virology of Epstein-Barr virus Philos. Trans. R. Soc., B 2001, 356, 437-459
80. Dirmeier, U.; Hoffmann, R.; Kilger, E.; Schultheiss, U.; Briseno, C.; Gires, O.; Kieser, A.; Eick, D.; Sugden, B.; Hammerschmidt, W. Latent membrane protein 1 of Epstein-Barr virus coordinately regulates proliferation with control of apoptosis Oncogene 2005, 24, 1711-1717
81. Schoggins, J. W.; Wilson, S. J.; Panis, M.; Murphy, M. Y.; Jones, C. T.; Bieniasz, P.; Rice, C. M. A diverse range of gene products are effectors of the type I interferon antiviral response Nature 2011, 472, 481-485
82. Smith, N.; Tierney, R.; Wei, W.; Vockerodt, M.; Murray, P. G.; Woodman, C. B.; Rowe, M. Induction of interferon-stimulated genes on the IL-4 response axis by Epstein-Barr virus infected human b cells; relevance to cellular transformation PloS One 2013, 8, e64868
83. Brzostek-Racine, S.; Gordon, C.; Van Scoy, S.; Reich, N. C. The DNA damage response induces IFN J. Immunol. 2011, 187, 5336-5345
84. Nikitin, P. A.; Yan, C. M.; Forte, E.; Bocedi, A.; Tourigny, J. P.; White, R. E.; Allday, M. J.; Patel, A.; Dave, S. S.; Kim, W.; Hu, K.; Guo, J.; Tainter, D.; Rusyn, E.; Luftig, M. A. An ATM/Chk2-mediated DNA damage-responsive signaling pathway suppresses Epstein-Barr virus transformation of primary human B cells Cell Host Microbe 2010, 8, 510-522
85. Pearl, L. H. Structure and function in the uracil-DNA glycosylase superfamily Mutat. Res. 2000, 460, 165-181
86. Lee, J. H.; Bodmer, R.; Bier, E.; Karin, M. Sestrins at the crossroad between stress and aging Aging 2010, 2, 369-374
87. Wang, F.; Kikutani, H.; Tsang, S. F.; Kishimoto, T.; Kieff, E. Epstein-Barr virus nuclear protein 2 transactivates a cis-acting CD23 DNA element J. Virol. 1991, 65, 4101-4106
88. Shieh, B.; Schultz, J.; Guinness, M.; Lacy, J. Regulation of the human IgE receptor (Fc epsilonRII/CD23) by Epstein-Barr virus (EBV): Ku autoantigen binds specifically to an EBV-responsive enhancer of CD23 Int. Immunol. 1997, 9, 1885-1895
89. Ling, P. D.; Hsieh, J. J.; Ruf, I. K.; Rawlins, D. R.; Hayward, S. D. EBNA-2 upregulation of Epstein-Barr virus latency promoters and the cellular CD23 promoter utilizes a common targeting intermediate, CBF1 J. Virol. 1994, 68, 5375-5383
90. Cheung, R. K.; Dosch, H. M. The growth transformation of human B cells involves superinduction of hsp70 and hsp90 Virology 1993, 193, 700-708
91. Ellen, T. P.; Ke, Q.; Zhang, P.; Costa, M. NDRG1, a growth and cancer related gene: regulation of gene expression and function in normal and disease states Carcinogenesis 2008, 29, 2-8
92. Lachat, P.; Shaw, P.; Gebhard, S.; van Belzen, N.; Chaubert, P.; Bosman, F. T. Expression of NDRG1, a differentiation-related gene, in human tissues Histochem. Cell Biol. 2002, 118, 399-408